Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03781960
Title Abemaciclib and Nivolumab for Subjects With Hepatocellular Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Abramson Cancer Center of the University of Pennsylvania

hepatocellular carcinoma


Abemaciclib + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST